FDA Plants OB-GYNs on Implant Addiction Therapy Committee; Titan Harvests Yes Vote
This article was originally published in RPM Report
Executive Summary
An advisory committee reviewing Titan’s Probuphine for abuse dependence leaned heavily on reassuring safety perspectives of two guest members invited for their particular expertise. No, they weren’t addiction experts. They were gynecologists.